XML 52 R33.htm IDEA: XBRL DOCUMENT v3.20.4

Revenues (Tables)

12 Months Ended

Dec. 31, 2020

Revenues [Abstract]

Schedule of net product revenues by product

The Company’s net product revenues consisted of the following for the years ended December 31:

						2020						2019						2018
Products:
Kristalose						$	15,567,562					$	12,895,120					$	12,055,625
Vibativ						10,870,990						8,691,550						5,075,057
Caldolor						5,336,943						5,222,282						5,001,997
Acetadote						1,874,206						3,824,449						4,284,111
Omeclamox-Pak						257,088						837,829						623,297
Vaprisol						1,077,227						936,615						1,763,874
RediTrex						856,657						—						—
Total net product revenues						$	35,840,673					$	32,407,845					$	28,803,961

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenuesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration